0
     

Report Added
Report already added
Global Xenotransplantation Market By Animal Type (Pig, Rabbit, Baboon, Others), By Xeno Product (Organs, Tissues, Cells), By Organs (Kidney, Liver, Heart, Cornea, Others), By End User (Hospitals, Transplant Centers, Others), and By Region, Competition Forecast and Opportunities, 2027

Global Xenotransplantation Market By Animal Type (Pig, Rabbit, Baboon, Others), By Xeno Product (Organs, Tissues, Cells), By Organs (Kidney, Liver, Heart, Cornea, Others), By End User (Hospitals, Transplant Centers, Others), and By Region, Competition Forecast and Opportunities, 2027

The global xenotransplantation market is anticipated to register a steady CAGR during the forecast period, 2023-2027. The demand for the global xenotransplantation market is primarily driven by factors such as the scarcity of organs for human transplantation and the developments in organ transplantation technologies. The rise in the prevalence of chronic diseases and the high-end investments made by market players in research and development activities are expected to influence the market demand. Growing incidences of organ failure, as well as the rise in success and better post-transplant outcomes, are increasing the chances of organ transplantation around the globe. There is a severe organ scarcity crisis due to the lack of sufficient organs for transplantation to satisfy the current demand. The number of people dying while waiting for a transplant and those on the waiting list has increased. There is a severe organ shortage issue due to the lack of sufficient organs for transplantation to match the current demand. The lack of organs prevents patients from leading healthy lives and raises the price of their medical treatment. The procedure known as xenotransplantation gives patients who need organ transplants the option of receiving organs from non-human animals. Thus, the improvements in organ transplantation technologies to meet current donor demand are expected to fuel the global xenotransplantation market growth in the coming years.
The global xenotransplantation market is segmented into animal type, xeno product, end user, regional distribution, and competitive landscape. Based on animal type, the market is divided into pig, rabbit, baboon, and others. Pigs are expected to hold the largest market share in the forecast period, 2023-2027. They are preferred because they expand rapidly and can produce large litters. Pigs' internal organs are roughly the same size as those of children and infants. Pigs can be bred under microbiologically regulated conditions to meet high health requirements.
The major market players operating in the global xenotransplantation market are United Therapeutics Corporation, Immerge BioTherapeutics, Inc, eGenesis, Inc., Infigen, Inc., NZeno Limited, recombinetics (Makana Therapeutics), Miromatrix Medical Inc., Optipharm Co. Ltd, Xeno Transplants Corporation, Smithfield Foods, Inc.

Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023–2027

Objective of the Study:

•To analyze the historical growth in the market size of the global xenotransplantation market from 2017 to 2021.
•To estimate and forecast the market size of global xenotransplantation market from 2022 to 2027 and growth rate until 2027.
•To classify and forecast the global xenotransplantation market based on animal type, xeno product, end user, region, and company.
•To identify the dominant region or segment in the global xenotransplantation market.
•To identify drivers and challenges for the global xenotransplantation market.
•To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global xenotransplantation market.
•To identify and analyze the profiles of leading players operating in the global xenotransplantation market.
•To identify key sustainable strategies adopted by market players in global xenotransplantation market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of the Global xenotransplantation market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
•Market research and consulting firms
•Government bodies such as regulating authorities and policy makers
•Organizations, forums, and alliances
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as product manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:
In this report, global xenotransplantation market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•Xenotransplantation Market, By Animal Type:
oPig
oRabbit
oBaboon
oOthers
•Xenotransplantation Market, By Xeno Product:
oOrgans
Kidney
Liver
Heart
Cornea
Others
oTissues
oCells
•Xenotransplantation Market, By End User:
oHospitals
oTransplant Centers
oOthers
•Xenotransplantation Market, By Region:
oNorth America
United States
Canada
Mexico
oAsia-Pacific
China
India
Japan
Australia
South Korea
oEurope
Germany
France
United Kingdom
Spain
Italy
oSouth America
Brazil
Argentina
Colombia
oMiddle East & Africa
South Africa
UAE
Saudi Arabia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global xenotransplantation market.

Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information
•Detailed analysis and profiling of additional market players (up to five).
Table of Content

1.Product Overview
2.Research Methodology
3.Executive Summary
4.Impact of COVID-19 on Global Xenotransplantation Market
5.Voice of Customer
5.1.Xenotransplantation Awareness
5.2.Factors Contributing Switch to Xenotransplantation
5.3.Preference, By Animal Type
5.4.Barriers to Adoption of Xenotransplantation
6.Clinical Trial Analysis
7.Patent Analysis
8.Successful Xenotransplantation Case Studies
9.Global Xenotransplantation Market Outlook
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.By Animal Type (Pig, Rabbit, Baboon, Others)
9.2.2.By Xeno Product (Organs, Tissues, Cells)
9.2.2.1.By Organs (Kidney, Liver, Heart, Cornea, Others)
9.2.3.By End User (Hospitals, Transplant Centers, Others)
9.2.4.By Company (2021)
9.2.5.By Region
9.3.Product Market Map
10.North America Xenotransplantation Market Outlook
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.By Animal Type (Pig, Rabbit, Baboon, Others)
10.2.2.By Xeno Product (Organs, Tissues, Cells)
10.2.2.1.By Organs (Kidney, Liver, Heart, Cornea, Others)
10.2.3.By End User (Hospitals, Transplant Centers, Others)
10.2.4.By Country
10.3.Policy & Regulatory Landscape
10.4.North America: Country Analysis
10.4.1.United States Xenotransplantation Market Outlook
10.4.1.1.Market Size & Forecast
10.4.1.1.1.By Value
10.4.1.2.Market Share & Forecast
10.4.1.2.1.By Animal Type
10.4.1.2.2.By Xeno Product
10.4.1.2.3.By End User
10.4.2.Mexico Xenotransplantation Market Outlook
10.4.2.1.Market Size & Forecast
10.4.2.1.1.By Value
10.4.2.2.Market Share & Forecast
10.4.2.2.1.By Animal Type
10.4.2.2.2.By Xeno Product
10.4.2.2.3.By End User
10.4.3.Canada Xenotransplantation Market Outlook
10.4.3.1.Market Size & Forecast
10.4.3.1.1.By Value
10.4.3.2.Market Share & Forecast
10.4.3.2.1.By Animal Type
10.4.3.2.2.By Xeno Product
10.4.3.2.3.By End User
11.Europe Xenotransplantation Market Outlook
11.1.Market Size & Forecast
11.1.1.By Value
11.2.Market Share & Forecast
11.2.1.By Animal Type (Pig, Rabbit, Baboon, Others)
11.2.2.By Xeno Product (Organs, Tissues, Cells)
11.2.2.1.By Organs (Kidney, Liver, Heart, Cornea, Others)
11.2.3.By End User (Hospitals, Transplant Centers, Others)
11.2.4.By Country
11.3.Policy & Regulatory Landscape
11.4.Europe: Country Analysis
11.4.1.France Xenotransplantation Market Outlook
11.4.1.1.Market Size & Forecast
11.4.1.1.1.By Value
11.4.1.2.Market Share & Forecast
11.4.1.2.1.By Animal Type
11.4.1.2.2.By Xeno Product
11.4.1.2.3.By End User
11.4.2.Germany Xenotransplantation Market Outlook
11.4.2.1.Market Size & Forecast
11.4.2.1.1.By Value
11.4.2.2.Market Share & Forecast
11.4.2.2.1.By Animal Type
11.4.2.2.2.By Xeno Product
11.4.2.2.3.By End User
11.4.3.United Kingdom Xenotransplantation Market Outlook
11.4.3.1.Market Size & Forecast
11.4.3.1.1.By Value
11.4.3.2.Market Share & Forecast
11.4.3.2.1.By Animal Type
11.4.3.2.2.By Xeno Product
11.4.3.2.3.By End User
11.4.4.Italy Xenotransplantation Market Outlook
11.4.4.1.Market Size & Forecast
11.4.4.1.1.By Value
11.4.4.2.Market Share & Forecast
11.4.4.2.1.By Animal Type
11.4.4.2.2.By Xeno Product
11.4.4.2.3.By End User
11.4.5.Spain Xenotransplantation Market Outlook
11.4.5.1.Market Size & Forecast
11.4.5.1.1.By Value
11.4.5.2.Market Share & Forecast
11.4.5.2.1.By Animal Type
11.4.5.2.2.By Xeno Product
11.4.5.2.3.By End User
12.Asia-Pacific Xenotransplantation Market Outlook
12.1.Market Size & Forecast
12.1.1.By Value
12.2.Market Share & Forecast
12.2.1.By Animal Type (Pig, Rabbit, Baboon, Others)
12.2.2.By Xeno Product (Organs, Tissues, Cells)
12.2.2.1.By Organs (Kidney, Liver, Heart, Cornea, Others)
12.2.3.By End User (Hospitals, Transplant Centers, Others)
12.2.4.By Country
12.3.Policy & Regulatory Landscape
12.4.Asia-Pacific: Country Analysis
12.4.1.China Xenotransplantation Market Outlook
12.4.1.1.Market Size & Forecast
12.4.1.1.1.By Value
12.4.1.2.Market Share & Forecast
12.4.1.2.1.By Animal Type
12.4.1.2.2.By Xeno Product
12.4.1.2.3.By End User
12.4.2.India Xenotransplantation Market Outlook
12.4.2.1.Market Size & Forecast
12.4.2.1.1.By Value
12.4.2.2.Market Share & Forecast
12.4.2.2.1.By Animal Type
12.4.2.2.2.By Xeno Product
12.4.2.2.3.By End User
12.4.3.South Korea Xenotransplantation Market Outlook
12.4.3.1.Market Size & Forecast
12.4.3.1.1.By Value
12.4.3.2.Market Share & Forecast
12.4.3.2.1.By Animal Type
12.4.3.2.2.By Xeno Product
12.4.3.2.3.By End User
12.4.4.Japan Xenotransplantation Market Outlook
12.4.4.1.Market Size & Forecast
12.4.4.1.1.By Value
12.4.4.2.Market Share & Forecast
12.4.4.2.1.By Animal Type
12.4.4.2.2.By Xeno Product
12.4.4.2.3.By End User
12.4.5.Australia Xenotransplantation Market Outlook
12.4.5.1.Market Size & Forecast
12.4.5.1.1.By Value
12.4.5.2.Market Share & Forecast
12.4.5.2.1.By Animal Type
12.4.5.2.2.By Xeno Product
12.4.5.2.3.By End User
13.South America Xenotransplantation Market Outlook
13.1.Market Size & Forecast
13.1.1.By Value
13.2.Market Share & Forecast
13.2.1.By Animal Type (Pig, Rabbit, Baboon, Others)
13.2.2.By Xeno Product (Organs, Tissues, Cells)
13.2.2.1.By Organs (Kidney, Liver, Heart, Cornea, Others)
13.2.3.By End User (Hospitals, Transplant Centers, Others)
13.2.4.By Country
13.3.Policy & Regulatory Landscape
13.4.South America: Country Analysis
13.4.1.Brazil Xenotransplantation Market Outlook
13.4.1.1.Market Size & Forecast
13.4.1.1.1.By Value
13.4.1.2.Market Share & Forecast
13.4.1.2.1.By Animal Type
13.4.1.2.2.By Xeno Product
13.4.1.2.3.By End User
13.4.2.Argentina Xenotransplantation Market Outlook
13.4.2.1.Market Size & Forecast
13.4.2.1.1.By Value
13.4.2.2.Market Share & Forecast
13.4.2.2.1.By Animal Type
13.4.2.2.2.By Xeno Product
13.4.2.2.3.By End User
13.4.3.Colombia Xenotransplantation Market Outlook
13.4.3.1.Market Size & Forecast
13.4.3.1.1.By Value
13.4.3.2.Market Share & Forecast
13.4.3.2.1.By Animal Type
13.4.3.2.2.By Xeno Product
13.4.3.2.3.By End User
14.Middle East and Africa Xenotransplantation Market Outlook
14.1.Market Size & Forecast
14.1.1.By Value
14.2.Market Share & Forecast
14.2.1.By Animal Type (Pig, Rabbit, Baboon, Others)
14.2.2.By Xeno Product (Organs, Tissues, Cells)
14.2.2.1.By Organs (Kidney, Liver, Heart, Cornea, Others)
14.2.3.By End User (Hospitals, Transplant Centers, Others)
14.2.4.By Country
14.3.Policy & Regulatory Landscape
14.4.MEA: Country Analysis
14.4.1.South Africa Xenotransplantation Market Outlook
14.4.1.1.Market Size & Forecast
14.4.1.1.1.By Value
14.4.1.2.Market Share & Forecast
14.4.1.2.1.By Animal Type
14.4.1.2.2.By Xeno Product
14.4.1.2.3.By End User
14.4.2.Saudi Arabia Xenotransplantation Market Outlook
14.4.2.1.Market Size & Forecast
14.4.2.1.1.By Value
14.4.2.2.Market Share & Forecast
14.4.2.2.1.By Animal Type
14.4.2.2.2.By Xeno Product
14.4.2.2.3.By End User
14.4.3.UAE Xenotransplantation Market Outlook
14.4.3.1.Market Size & Forecast
14.4.3.1.1.By Value
14.4.3.2.Market Share & Forecast
14.4.3.2.1.By Animal Type
14.4.3.2.2.By Xeno Product
14.4.3.2.3.By End User
15.Market Dynamics
15.1.Drivers
15.2.Challenges
16.Market Trends & Developments
17.SWOT Analysis: Global Xenotransplantation Market
18.Competitive Landscape (Inclusive of SWOT Analysis of Players Profiled)
18.1.United Therapeutics Corporation
18.2.Immerge BioTherapeutics, Inc
18.3.eGenesis, Inc.
18.4.Infigen, Inc.
18.5.NZeno Limited
18.6.recombinetics (Makana Therapeutics)
18.7.Miromatrix Medical Inc.
18.8.Optipharm Co. Ltd
18.9.Xeno Transplants Corporation
18.10.Smithfield Foods, Inc.
19.Strategic Recommendations

Report Title: Global Xenotransplantation Market By Animal Type (Pig, Rabbit, Baboon, Others), By Xeno Product (Organs, Tissues, Cells), By Organs (Kidney, Liver, Heart, Cornea, Others), By End User (Hospitals, Transplant Centers, Others), and By Region, Competition Forecast and Opportunities, 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW